psychiatryRounds

Connecting Psychiatry - Expert community for all mental health professionals

FDA Okays Risperidone for Schizophrenia and Bipolar Disorder in Kids

(PSYCHIATRIC TIMES) - ROCKVILLE, Md., Aug. 22 -- The FDA approved risperidone (Risperdal) today for schizophrenia in adolescents and for bipolar I disorder in pediatric patients as young as 10.

The action marks the first time that the FDA has approved an atypical antipsychotic medication for use in children, said Thomas Laughren, M.D., director of the division of psychiatry products at the FDA's Center for Drug Evaluation and Research.

At a press briefing Dr. Laughren said the FDA was aware that risperidone was already used off-label to treat both conditions in children. Yet, he pointed out that the three trials submitted for approval provided evidence that risperidone is effective in children at doses of 1 to 3 mg and increasing the dose to 3 to 6 mg did not increase efficacy.

For full article, please visit:
http://www.psychiatrictimes.com/bipolar-disorder/article/10162/28974

Views: 5

Comment

You need to be a member of psychiatryRounds to add comments!

Join psychiatryRounds


psychiatryRounds Social Media

Sponsors

CMEinfo: Board Reviews in Anesthesia, Cardiology, Internal Medicine, Radiology

© 2019   Created by PsychiatryRounds Team.   Powered by

Badges  |  Report an Issue  |  Terms of Service